News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
Presentation ESC 2024 Continuation versus Interruption of Oral Anticoagulation during TAVI Presenter: Dirk-Jan van Ginkel August 31, 2024
News Daily News Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea Todd Neale August 27, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2024 Shelley Wood July 31, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Leaks After LAAO Do Matter, Experts Agree Todd Neale June 10, 2024
Presentation NY Valves 2024 Surgical Closure of the LAA: Patient Selection, Procedural Success, and Postprocedural Anticoagulation Strategies Presenter: Guido Ascione June 07, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Conference News SCAI 2024 PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry L.A. McKeown May 07, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023